VHT Stock Overview
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand.
Volpara Health Technologies Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.63|
|52 Week High||AU$1.10|
|52 Week Low||AU$0.40|
|1 Month Change||-3.85%|
|3 Month Change||4.17%|
|1 Year Change||-42.13%|
|3 Year Change||-64.89%|
|5 Year Change||6.84%|
|Change since IPO||25.00%|
Recent News & Updates
Calculating The Intrinsic Value Of Volpara Health Technologies Limited (ASX:VHT)Jun 03
Does Volpara Health Technologies (ASX:VHT) Have A Healthy Balance Sheet?Mar 24
Volpara Health Technologies (ASX:VHT) Shareholders Booked A 93% Gain In The Last Three YearsJan 28
Volpara Health Technologies (ASX:VHT) Is Using Debt SafelyDec 24
Here's What We Think About Volpara Health Technologies' (ASX:VHT) CEO PayNov 19
|VHT||AU Healthcare Services||AU Market|
Return vs Industry: VHT underperformed the Australian Healthcare Services industry which returned -13.4% over the past year.
Return vs Market: VHT underperformed the Australian Market which returned -4.7% over the past year.
|VHT Average Weekly Movement||6.8%|
|Healthcare Services Industry Average Movement||10.9%|
|Market Average Movement||8.9%|
|10% most volatile stocks in AU Market||15.8%|
|10% least volatile stocks in AU Market||4.1%|
Stable Share Price: VHT is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: VHT's weekly volatility (7%) has been stable over the past year.
About the Company
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients’ risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products.
Volpara Health Technologies Limited Fundamentals Summary
|VHT fundamental statistics|
Is VHT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|VHT income statement (TTM)|
|Cost of Revenue||NZ$2.61m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.052|
|Net Profit Margin||-43.09%|
How did VHT perform over the long term?See historical performance and comparison